Pricing Log in Create free account
Saturday 17 October 2026 Export SYK’s income statement to Excel — free account

Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Stryker Corporation 10-K filed Feb 12, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed · accepted 11:47 AM ET · Document on sec.gov · Filing index

Red flags

  • Impairment

    Stryker Corporation recorded a goodwill impairment of $456.0 million in fiscal 2024

    10-K filed · The filing · sec.gov